Latest News

Confirmed: Growth in overdose deaths is exponential


 

FROM SCIENCE

Overdose death rates for individual drugs show no particular patterns since the turn of the century, but the exponential growth of overall drug mortality actually started before the opioid epidemic, according to an analysis of almost 600,000 unintentional overdose deaths since 1979.

Mortality from unintentional drug overdoses, 1979-2016

“The current epidemic of overdose deaths due to prescription opioids, heroin, and fentanyl appears to be the most recent manifestation of a more fundamental, longer-term process,” senior author Donald S. Burke, MD, of the University of Pittsburgh, said in a written statement.

Overdose mortality from all types of drugs rose from 1.13 per 100,000 population in 1979 to 16.96 per 100,000 in 2016, based on data for 599,255 deaths from unintentional drug overdoses in the National Vital Statistics System, they reported in Science.

When the investigators plotted annual drug overdose mortality over that 38-year period, they saw a smooth upward exponential curve with a doubling time of about 9 years. “This remarkably smooth, long-term epidemic growth pattern really caught our attention,” Dr. Burke said. “If we can figure it out, we should be able to bend that curve downward.”

The individual drug types that make up the whole, however, are a different story. “There is no regular or predictable pattern to the overdose rates for any of these drugs. Cocaine overdose death rates curved down and up and down and back up over the past 20 years. Methadone deaths have been on a downturn since the mid-2000s. Prescription opioids have been on a fairly steady, steep climb. Heroin deaths shot up in 2010, followed in 2013 by synthetic opioids, such as fentanyl,” lead author Hawre Jalal, MD, PhD, also of the university, said in the statement.

Geographic and demographic analyses produced the same absence of patterns. “Indeed, these findings add to the paradox by revealing how disparate the individual drug epidemics are,” the researchers wrote.

The study was supported by grants from the Centers for Disease Control and Prevention and the Robert Wood Johnson Foundation. The investigators said they have no competing interests.

SOURCE: Jalal H et al. Science 2018 Sep 20. doi: 10.1126/science.aau1184.

Recommended Reading

For some SUD patients, kratom may be a self-treatment tool
MDedge Rheumatology
Many veterans with comorbid pain and OUD not receiving MAT
MDedge Rheumatology
Fentanyl analogs nearly double their overdose death toll
MDedge Rheumatology
Malpractice and pain management
MDedge Rheumatology
Opioid use has not declined meaningfully
MDedge Rheumatology
FDA proposes broader outcomes for OUD treatment drug approvals
MDedge Rheumatology
Opioids, other causes linked to shorter lifespans, rising midlife mortality
MDedge Rheumatology
FDA warns kratom vendors about unproven claims
MDedge Rheumatology
More than half of urine drug screens showed improper medication use
MDedge Rheumatology
FDA issues new REMS for immediate-release opioids
MDedge Rheumatology